Please login to the form below
Video: Immuno-oncology therapies
Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Article: Market access in Brazil
- All eyes on Spinraza
Research Partnership
- China: How to strategise and win in the world's fastest changing healthcare market
Research Partnership
- Infographic: Preparing to launch a new asset and in need of demand assessment research?
- Download our pre-launch checklist
Research Partnership
- Article: Engaging patient advocacy groups
- The key to conducting effective rare disease research
Research Partnership
- Webcast: Harnessing the power of social: How to generate fresh insights for your business using social media listening
Research Partnership
- Article: Like, Like, Like: Harnessing the power of social media insights
Research Partnership
